Literature DB >> 29588060

Light Therapy in Parkinson's Disease: Towards Mechanism-Based Protocols.

Karim Fifel1, Aleksandar Videnovic2.   

Abstract

A growing body of work is investigating the safety and efficacy of light in Parkinson's disease (PD). Here we discuss the potential of this emerging therapy to improve both motor and non-motor symptoms of PD. We also highlight directions for future basic, translational, and clinical research that are critical for the development of mechanism-based protocols of light therapy in PD.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  bright light; chronotherapy; non-motor symptoms

Mesh：

Year:  2018        PMID： 29588060      PMCID： PMC5924622          DOI： 10.1016/j.tins.2018.03.002

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN： 0166-2236            Impact factor:   13.837


  12 in total

Review 1.  Alterations of the circadian system in Parkinson's disease patients.

Authors:  Karim Fifel
Journal:  Mov Disord       Date:  2016-11-15       Impact factor: 10.338

Review 2.  Non-motor features of Parkinson disease.

Authors:  Anthony H V Schapira; K Ray Chaudhuri; Peter Jenner
Journal:  Nat Rev Neurosci       Date:  2017-06-08       Impact factor: 34.870

3.  A historical justification for and retrospective analysis of the systematic application of light therapy in Parkinson's disease.

Authors:  Gregory L Willis; Cleo Moore; Stuart M Armstrong
Journal:  Rev Neurosci       Date:  2012-03-01       Impact factor: 4.353

4.  Light deprivation damages monoamine neurons and produces a depressive behavioral phenotype in rats.

Authors:  M M C Gonzalez; G Aston-Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-17       Impact factor: 11.205

5.  Primary and secondary features of Parkinson's disease improve with strategic exposure to bright light: a case series study.

Authors:  Gregory L Willis; E John D Turner
Journal:  Chronobiol Int       Date:  2007       Impact factor: 2.877

6.  Bright light therapy in Parkinson's disease: a pilot study.

Authors:  Sebastian Paus; Tanja Schmitz-Hübsch; Ullrich Wüllner; Antje Vogel; Thomas Klockgether; Michael Abele
Journal:  Mov Disord       Date:  2007-07-30       Impact factor: 10.338

7.  Timed Light Therapy for Sleep and Daytime Sleepiness Associated With Parkinson Disease: A Randomized Clinical Trial.

Authors:  Aleksandar Videnovic; Elizabeth B Klerman; Wei Wang; Angelica Marconi; Teresa Kuhta; Phyllis C Zee
Journal:  JAMA Neurol       Date:  2017-04-01       Impact factor: 18.302

8.  Effects of a higher dose of near-infrared light on clinical signs and neuroprotection in a monkey model of Parkinson's disease.

Authors:  Cécile Moro; Nabil El Massri; Fannie Darlot; Napoleon Torres; Claude Chabrol; Diane Agay; Vincent Auboiroux; Daniel M Johnstone; Jonathan Stone; John Mitrofanis; Alim-Louis Benabid
Journal:  Brain Res       Date:  2016-07-07       Impact factor: 3.610

9.  A double-blind randomized controlled trial to assess the effect of bright light therapy on depression in patients with Parkinson's disease.

Authors:  Sonja Rutten; Chris Vriend; Jan H Smit; Henk W Berendse; Adriaan W Hoogendoorn; Odile A van den Heuvel; Ysbrand D van der Werf
Journal:  BMC Psychiatry       Date:  2016-10-21       Impact factor: 3.630

10.  Chemogenetic Activation of Melanopsin Retinal Ganglion Cells Induces Signatures of Arousal and/or Anxiety in Mice.

Authors:  Nina Milosavljevic; Jasmina Cehajic-Kapetanovic; Christopher A Procyk; Robert J Lucas
Journal:  Curr Biol       Date:  2016-07-14       Impact factor: 10.834
View more
  6 in total

Review 1.  Chronotherapies for Parkinson's disease.

Authors:  Karim Fifel; Aleksandar Videnovic
Journal:  Prog Neurobiol       Date:  2019-01-15       Impact factor: 11.685

2.  Effects of bromelain on motor responses following intra-medial forebrain bundle 6-OHDA injection in rat model of parkinsonism.

Authors:  Temitope Samson Adu; Musa Vuyisile Mabandla
Journal:  Metab Brain Dis       Date:  2019-07-22       Impact factor: 3.584

Review 3.  Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease.

Authors:  Jee-Young Lee; Antonio Martin-Bastida; Ane Murueta-Goyena; Iñigo Gabilondo; Nicolás Cuenca; Paola Piccini; Beomseok Jeon
Journal:  Nat Rev Neurol       Date:  2022-02-17       Impact factor: 44.711

4.  Efficacy and Safety of Light Therapy as a Home Treatment for Motor and Non-Motor Symptoms of Parkinson Disease: A Meta-Analysis.

Authors:  Wenjie Sun; Junqiang Yan; Jiannan Wu; Hongxia Ma
Journal:  Med Sci Monit       Date:  2022-01-07

5.  Changes in the Brain Activity and Visual Performance of Patients with Strabismus and Amblyopia after a Compete Cycle of Light Therapy.

Authors:  Danjela Ibrahimi; Jorge D Mendiola-Santibañez; Enoé Cruz-Martínez; Alfonso Gómez-Espinosa; Irineo Torres-Pacheco
Journal:  Brain Sci       Date:  2021-05-18

6.  Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson's disease.

Authors:  Isabel Ortuño-Lizarán; Gema Esquiva; Thomas G Beach; Geidy E Serrano; Charles H Adler; Pedro Lax; Nicolás Cuenca
Journal:  Acta Neuropathol Commun       Date:  2018-09-10       Impact factor: 7.801
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.